ANDA 204867, held by Actavis Labs Fl Inc. Prednisone.
As of Nov 14, 2026, ANDA 204867 (Prednisone), held by Actavis Labs Fl Inc, was first approved by FDA on Apr 25, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 25, 2017 | Original application | Approved | None posted |
| Prednisone1MG · tablet, delayed release;oral | Prednisone | Discontinued |
| Prednisone2MG · tablet, delayed release;oral | Prednisone | Discontinued |
| Prednisone5MG · tablet, delayed release;oral | Prednisone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
